NCT07487155 Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Disorder
| NCT ID | NCT07487155 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Brest |
| Condition | Attention Deficit Disorder With Hyperactivity (ADHD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 39 participants |
| Start Date | 2026-08-03 |
| Primary Completion | 2028-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 39 participants in total. It began in 2026-08-03 with a primary completion date of 2028-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Substance use disorders (SUD) and attention deficit disorder with or without hyperactivity (ADHD) are frequently co-morbid, particularly among people under court supervision. The coexistence of these disorders increases the social and legal vulnerability of individuals. Better identification of ADHD in vulnerable people with SUD is essential to improving their care. This project aims to provide appropriate support for this at-risk population.
Eligibility Criteria
Inclusion Criteria: * Adult, under the supervision of the justice system or monitored by a correctional facility * Diagnosis of Substance Use Disorder (SUD) * Diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) * No objection from the patient * Affiliated with a Social Security system Exclusion Criteria: * Severe or decompensated psychiatric disorders * Severe cognitive impairment * Lack of understanding of the French language * Refusal to participate
Contact & Investigator
Morgane GUILLOU-LANDREAT, MD
PRINCIPAL INVESTIGATOR
CHU Brest
Frequently Asked Questions
Who can join the NCT07487155 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Attention Deficit Disorder With Hyperactivity (ADHD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07487155 currently recruiting?
Yes, NCT07487155 is actively recruiting participants. Contact the research team at marie.barais@gmail.com for enrollment information.
Where is the NCT07487155 trial being conducted?
This trial is being conducted at Brest, France.
Who is sponsoring the NCT07487155 clinical trial?
NCT07487155 is sponsored by University Hospital, Brest. The principal investigator is Morgane GUILLOU-LANDREAT, MD at CHU Brest. The trial plans to enroll 39 participants.